A Case of Successful Treatment of Gram-Negative Sepsis Associated with Toxic Myelosuppression in a Patient with HIV-Associated Non-Hodgkin’s Lymphoma

This article presents a clinical case of successful treatment of gram-negative sepsis in a patient with HIV-associated non-Hodgkin’s lymphoma. The patient was admitted to the intensive care unit in critical condition after the third course of polychemotherapy according to the ICE scheme. The severity of the condition was due to nosocomial pneumonia, septic shock, multiple organ failure, immunosuppression against the background of PCT and HIV infection, and the lack of specific treatment for HIV infection. Despite the absence of a positive blood culture throughout the entire treatment period, the diagnosis of sepsis was not in doubt, according to the criteria of the 2001 International Consensus Conference on Sepsis. The cause of the septic state was the combined effect of bacteria (Pseudomonas aeruginosa) and fungi (Candida albicans, Candida krusei) against the background of persistent HIV infection. The patient’s pneumonia was destructive and was twice aggravated by spontaneous pneumothorax. At the initial stage, intensive therapy led to positive dynamics. The severity of the systemic inflammatory response decreased, the acute respiratory insufficiency regressed, the X-ray pattern improved, and laboratory parameters stabilized. Despite the continued intensive therapy in the former volume on day 19, a sharply negative dynamics was noted, which led to a re-transfer of the patient to artificial ventilation of the lungs. The replacement of antibiotics and the specific treatment of HIV infection led to the patient’s recovery. In the future, chemotherapy was not carried out. Remission of the disease lasts six years.

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29(7): 1303-1310. doi: 10.1097/00003246200107000-00002

2. Okamura I, Tome R. Presepsin: A new biomarker for predicting and diagnosing sepsis. Laboratoriya. 2014; 1: 9-10. (In Russ.)

3. Karsanov AM, Sazhin VP, Maskin SS, Remizov OV, Korovin AYa. Sepsis. Vladikavkaz: CPI IP Tsopanova A.Yu.; 2017. (In Russ.)

4. Ryabukhina YuE, Demina EA, Larionova VB. The problem of infectious complications in patients with Hodgkin’s lymphoma with unfavorable prognosis. Journal of N.N. Blokhin Russian Cancer Research Center RAMS. 2008; 19(2): 50-61. (In Russ.)

5. Mauch PM, Kalish LA, Marcus KC, Shulman LN, Krill E, Tarbell NJ, et al. Long-term survival in Hodgkin’s disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am. 1995; 1(1): 33-42.

6. Keselman SA. Induction anticancer chemotherapy for acute respiratory failure in patients with hematological malignancies: Abstract of the Dissertation of Cand. Sc. (Med.). Moscow; 2015. (In Russ.)

7. Azoulay E, Moreau D, Alberti C, Leleu G, Adrie C, Barboteu M, et al. Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med. 2000; 26(12): 1817-1823. doi: 10.1007/s001340051350

8. Klimko NN (ed.). Russian national guidelines Diagnosis and treatment of fungal infections in the intensive care unit. Moscow: Borges; 2010. (In Russ.)

9. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003; 29(4): 530-538. doi: 10.1007/s00134-003-1662-x

10. Seymour CW, Liu VX, Iwashyna TJ, Rea D, Scherag A, Rubenfeld G, et al. Assessment of clinical criteria for sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8): 762-774. doi: 10.1001/jama.2016.0288

11. Poddubnaya IV, Savcnenko VG (eds). Russian clinical guidelines for the diagnosis of treatment of lymphoproliferative diseases. Moscow: Media Medica; 2013. (In Russ.)